What is the cut-off score for the Cornell Scale for Depression in geriatric patients with dementia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cornell Scale for Depression in Dementia: Cut-off Score

The Cornell Scale for Depression in Dementia (CSDD) uses a cut-off score of ≥6 to detect significant depression in geriatric patients with dementia, with scores ranging from 0 to 38. 1, 2

Scoring Structure and Interpretation

  • The CSDD is a 19-item clinician-administered instrument where each item is rated: 0 = absent; 1 = mild to intermittent; 2 = severe, yielding a total score range of 0 to 38 (none to maximum depressive symptoms). 1

  • A score of ≥6 demonstrates optimal sensitivity (93%) and specificity (97%) for detecting depression in dementia populations. 2

  • The scale maintains its validity across the entire severity spectrum of MCI through dementia, making it particularly well-suited for detecting, tracking progression, and monitoring depression in cognitively impaired patients. 1

Administration Method

  • The CSDD is administered to both the patient and a care partner/informant, and critically, the patient does not need to be able to answer for the scale to be completed—this is a key advantage over self-report measures in dementia populations. 1

  • The dual-informant approach (patient interview plus caregiver interview) provides superior reliability compared to single-source assessments, with high interrater reliability (kappa = 0.67-0.74) and internal consistency (coefficient alpha = 0.84-0.98). 3, 4

Comparative Validity in Dementia

  • The CSDD is superior to the Geriatric Depression Scale (GDS) for patients with dementia. While the GDS loses validity as cognitive impairment worsens, the CSDD retains equal validity in both demented and non-demented populations. 5, 2

  • In Alzheimer's disease patients, the GDS shows only weak correlations with depression (r = 0.273-0.348) and fails to achieve adequate sensitivity/specificity, whereas the CSDD maintains robust psychometric properties. 5

  • The Alzheimer's Association specifically recommends the CSDD as one of the complementary behavioral assessment tools for comprehensive evaluation in patients with cognitive impairment and behavioral symptoms. 6

Clinical Context and Prevalence

  • In memory clinic populations, approximately 37.5% of patients score above 7 on the CSDD, and 14.1% score above 12, indicating substantial prevalence of depressive symptoms in dementia assessments. 7

  • Factors associated with higher CSDD scores include younger age, greater impairment in activities of daily living (ADL), previous depression history, and dementia types other than Alzheimer's disease. 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Cornell Scale for Depression in Dementia.

Biological psychiatry, 1988

Research

Use of the Cornell scale in nondemented patients.

Journal of the American Geriatrics Society, 1988

Guideline

Aggressive Behavior in Elderly Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.